Ilioinguinal Nerve Block in Transcatheter Aortic Valve Implantation
NCT ID: NCT05220813
Last Updated: 2022-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
88 participants
INTERVENTIONAL
2021-11-11
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analgesic Effect of Illiohypogastic & Ilioinguinal Nerve Block in TAVR - TF (Prospective Randomized Study)
NCT06362915
A Comparison Between Ketamine-lidocaine Versus Ketamine-fentanyl for Induction on the Hemodynamic Effects in Patients With Coronary Artery Disease
NCT05502211
Ketamine-lidocaine Versus Ketamine-fentanyl for Induction of Anesthesia in Patients With Left Ventricular Systolic Dysfunction Undergoing Elective Coronary Artery Bypass
NCT07248202
The Cardioprotective Effect of Intralipid in Decreasing the Ischemic Insults During Off-pump Coronary Artery Revascularization
NCT04806425
EIT Evaluation of Pulmonary Ventilation With Different Ropivacaine Concentrations in Intercostal Nerve Blockade
NCT07079436
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
local anesthetic group (control group)
44 patients will receive local infiltration anesthesia.
Lidocaine
local infiltration by lidocaine in the surgical site
ilioinguinal iliohypogastric group
44patients will receive ilioinguinal iliohypogastric nerve blocks
Bupivacain
44patients will receive bupivacaine in ilioinguinal \& iliohypogastric nerve blocks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaine
local infiltration by lidocaine in the surgical site
Bupivacain
44patients will receive bupivacaine in ilioinguinal \& iliohypogastric nerve blocks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both sexes.
* Age 18 and above
Exclusion Criteria
* Patients with severe pulmonary hypertension (PAP\>60 mmhg)
* Barrier to communications as language barrier or dementia.
* Patients' preference of general anesthesia.
* Surgical consideration as transapical, subclavian approach, extensive TEE requirements.
* Patients with history of allergy to any drugs used.
* Patients with psychiatric disease.
* Patients with neurocognitive or neurodegenerative disease.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ismail Mohammed
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ismail Mohammed Ibrahim
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
mohamed mohsen mohamed, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMASU R 187/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.